Russian government to support development of domestic API production

The Russian government plans to support the development of the domestic production of active pharmaceutical ingredients (APIs) by the provision of subsidies for their exports, according to Denis Manturov, an official spokesman of the Russian Minister of Industry and Trade, reports The Pharma Letter’s local correspondent.

As part of these plans, the government has prepared a package of amendments to the existing federal law “On the Turnover of Drugs in Russia,” which are aimed at supporting exports of domestic active ingredients.

Now companies can export their active ingredients only to those drugmakers that sell them in Russia and the CIS countries, however, thanks to the new amendments, the geography of supplies will be significantly expanded already this year.